BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05501054-completion@plaintrial.com
DTSTAMP:20261028T172815Z
DTSTART;VALUE=DATE:20261101
SUMMARY:Phase 1b/2 Trial of Ipilimumab\, Nivolumab\, and Ciforadenant (Aden
 osine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma
 . — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05501054
URL:https://plaintrial.com/trial/NCT05501054
END:VEVENT
END:VCALENDAR